MindMaze Therapeutics Holding (RLFTF)

[mc67]

$RLFTF Relief Appoints Gilles Della Corte, M.D. as Chief Medical Officer Geneva, Switzerland, September 04, 2020

– RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF) (“Relief” or the “Company“), a biopharmaceutical company with its lead compound aviptadil in advanced clinical development to treat severe COVID-19 patients, today announced the appointment of Gilles Della Corte, M.D., as Chief Medical Officer, effective immediately.

https://relieftherapeutics.com/relief-appoints-gilles-della-corte-m-d-as-chief-medical-officer/